The visual analog scale (VAS) demonstrates comparable validity for perennial allergic rhinitis (PAR) and nonallergic rhinitis (NAR) severity and quality-of-life (QoL) impairment, according to a study published online Dec. 23 in The Journal of Allergy and Clinical Immunology: In Practice.
Continue Reading this article here
